Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Oral Oncol ; 154: 106826, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38733949

ABSTRACT

OBJECTIVE: To describe the implementation of an oral cancer screening program at the Barretos Cancer Hospital (BCH) and present the outcome based on data obtained from 2014 to 2020. MATERIALS AND METHODS: The residents of the Regional Health District of Barretos (DRS-V) were personally invited by community health agents or nurses, and among 13,973 people, 15,222 oral examinations were carried out over the years in 18 of its municipalities. Oral examinations were performed at the Mobile Dental Unit and at the Prevention Department of the BCH. Inclusion criteria were being 35 years of age or older, having a personal history of tobacco or alcohol consumption, or having a lesion in the oral cavity found by community health agent or self-reported, regardless of age or risk factors. RESULTS AND CONCLUSION: The main result of our study was the stages of oral cancer among screen detected cases were smaller compared to cases in the hospital registry, in the state and in Brazil. Oral cancer detection rate per 1,000 oral examinations was 10.7.The early stages of oral cancer found by screening in primary care facilities or using mobile units suggest that, when organized, screening may improve the prognosis of oral cancer.


Subject(s)
Early Detection of Cancer , Mouth Neoplasms , Humans , Mouth Neoplasms/diagnosis , Mouth Neoplasms/epidemiology , Brazil/epidemiology , Early Detection of Cancer/methods , Male , Female , Middle Aged , Adult , Aged , Mass Screening/methods
2.
Transplant Proc ; 49(4): 893-897, 2017 May.
Article in English | MEDLINE | ID: mdl-28457420

ABSTRACT

The purpose of this article was to report the clinical and radiographic findings about a case of a man affected by severely atrophic maxilla to demonstrate the clinical proceedings associated with alveolar reconstruction destined for dental implant rehabilitation. The 3-dimensional augmentation of the alveolar ridge with the use of fresh-frozen bone graft, platelet-rich fibrin membrane, and titanium mesh suggests potential benefits to the development of the bone formation physiology. The treatment combination may result in an optimal prognosis and represents an option for reconstruction of bone defects. At 8 months after surgery, no evidence of complications was observed; the clinical examination and computerized tomographic scan revealed bone formation and installed implant stability.


Subject(s)
Alveolar Ridge Augmentation/methods , Bone Transplantation/methods , Dental Implantation, Endosseous/methods , Maxilla/surgery , Maxillary Diseases/surgery , Platelet-Rich Fibrin , Aged , Allografts , Alveolar Process/surgery , Atrophy/pathology , Atrophy/surgery , Dental Implants , Humans , Male , Maxilla/pathology , Maxillary Diseases/pathology , Surgical Mesh , Titanium
3.
Oral Dis ; 18(6): 548-57, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22360145

ABSTRACT

OBJECTIVE: Keratocystic odontogenic tumors (KOTs) can be treated with Carnoy's solution, although this treatment modality is not free from complications. It is important to verify the incidence of complications after the use of Carnoy's solution and compare these with the literature. MATERIALS AND METHODS: This study verified the effects of a complementary treatment for KOTs and assessed the incidence of such complications as recurrence, infection, sequestrum formation, mandibular fracture, dehiscence, and neuropathy. RESULTS: Twenty-two KOTs treated with Carnoy's solution combined with peripheral ostectomy were included, and the follow-up period varied from 12 to 78months with a mean of 42.9months. Complications included recurrence (4.5%), dehiscence (22.7%), infection (4.5%), and paresthesia (18.2%). No difference was found among lesions associated (9.1%) or not (0%) with nevoid basal cell carcinoma syndrome (P>0.05). Dehiscence was influenced by marsupialization (P<0.05), and paresthesia was observed exclusively in cases of mandibular canal fenestration (P<0.01). CONCLUSIONS: Complementary treatment with Carnoy's solution and peripheral ostectomy appear to provide efficient treatment for KOTs. Complications originating from the use of the solution are less frequent and less serious than complications associated with cryotherapy. Neuropathy seems to be related to direct contact between the solution and the epineurium.


Subject(s)
Acetic Acid/therapeutic use , Chloroform/therapeutic use , Ethanol/therapeutic use , Fixatives , Odontogenic Tumors/drug therapy , Acetic Acid/adverse effects , Adolescent , Adult , Aged , Child , Chloroform/adverse effects , Combined Modality Therapy , Ethanol/adverse effects , Female , Fixatives/adverse effects , Follow-Up Studies , Humans , Male , Mandibular Fractures/etiology , Mandibular Neoplasms/drug therapy , Mandibular Neoplasms/surgery , Mandibular Nerve/drug effects , Mandibular Nerve/physiopathology , Maxillary Neoplasms/drug therapy , Maxillary Neoplasms/surgery , Middle Aged , Neoplasm Recurrence, Local/pathology , Odontogenic Tumors/surgery , Osteotomy/adverse effects , Paresthesia/etiology , Postoperative Complications , Retrospective Studies , Surgical Wound Dehiscence/etiology , Surgical Wound Infection/etiology , Thermosensing/physiology , Time Factors , Touch/physiology , Trigeminal Nerve Injuries/etiology , Young Adult
4.
Bone Marrow Transplant ; 37(10): 955-9, 2006 May.
Article in English | MEDLINE | ID: mdl-16565740

ABSTRACT

Salivary gland dysfunction is a common sequela of hematopoietic progenitor cell transplantation (HPCT). The investigation of major salivary gland dysfunction with sodium pertechnetate scintigraphy is a non-invasive method that provides images of the parotid and submandibular glands. In this prospective trial, 20 HPCT patients were submitted to scintigraphic study with 99mTc-pertechenate and 67Ga in order to evaluate the major salivary glands early involvement following HPCT. Major salivary glands were evaluated prior to HCPT as well as at Days +30, +60 and +100 post transplant. Major salivary glands uptake and clearance of 99mTc-pertechenate results did not demonstrate any functional differences between pre- versus post transplant periods. Results of the 67Ga scan revealed inflammatory infiltration following HPCT, primarily in submandibular glands, suggest a persistent involvement of major salivary glands up to Day +100 after HPCT.


Subject(s)
Hematopoietic Stem Cell Transplantation/methods , Radionuclide Imaging/methods , Salivary Glands/diagnostic imaging , Salivary Glands/injuries , Transplantation, Homologous/methods , Adult , Female , Gallium/metabolism , Graft vs Host Disease , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Male , Middle Aged , Prospective Studies , Salivary Glands/metabolism , Submandibular Gland/metabolism , Technetium/metabolism , Transplantation, Homologous/adverse effects , Treatment Outcome , Xerostomia/etiology , Xerostomia/metabolism
5.
J Oral Pathol Med ; 34(8): 486-93, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16091116

ABSTRACT

BACKGROUND: The established pathologic criteria for minor salivary gland (MSG) involvement in chronic graft-vs.-host disease (cGVHD) could play a role in monitoring response to therapy. METHODS: We evaluated MSG sequential biopsies during cGVHD therapy in 14 allogeneic bone marrow transplantation (BMT) patients. Nine patients that did not develop GVHD after BMT entered the control group. Biopsies were examined using hematoxylin-eosin, Periodic acid-Schiff (PAS) and leukocyte common antigen staining. RESULTS: A significant loss of PAS+ acinar volume was observed at the diagnosis of cGVHD as much as at the end of treatment when compared with the control group. In the second evaluation, the inflammatory infiltrate was still greater than control group. CONCLUSIONS: The results suggest that persistent xerostomia after cGVHD treatment is because of maintenance of lymphocytic infiltrate and consequent absence of MSG secretory unit recovery. This data may be useful to provide improved insight into the histopathology of this organ involvement.


Subject(s)
Graft vs Host Disease/complications , Graft vs Host Disease/pathology , Salivary Glands, Minor/pathology , Xerostomia/etiology , Adolescent , Adult , Anti-Inflammatory Agents/therapeutic use , Biopsy , Bone Marrow Transplantation/adverse effects , Case-Control Studies , Chronic Disease , Cyclosporine/therapeutic use , Female , Graft vs Host Disease/drug therapy , Graft vs Host Disease/etiology , Humans , Immunosuppressive Agents/therapeutic use , Leukemia, Myeloid/therapy , Male , Middle Aged , Periodic Acid-Schiff Reaction , Prednisone/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...